Your browser doesn't support javascript.
loading
CD8+ T cell-intrinsic IL-6 signaling promotes resistance to anti-PD-L1 immunotherapy.
Huseni, Mahrukh A; Wang, Lifen; Klementowicz, Joanna E; Yuen, Kobe; Breart, Beatrice; Orr, Christine; Liu, Li-Fen; Li, Yijin; Gupta, Vinita; Li, Congfen; Rishipathak, Deepali; Peng, Jing; Senbabaoǧlu, Yasin; Modrusan, Zora; Keerthivasan, Shilpa; Madireddi, Shravan; Chen, Ying-Jiun; Fraser, Eleanor J; Leng, Ning; Hamidi, Habib; Koeppen, Hartmut; Ziai, James; Hashimoto, Kenji; Fassò, Marcella; Williams, Patrick; McDermott, David F; Rosenberg, Jonathan E; Powles, Thomas; Emens, Leisha A; Hegde, Priti S; Mellman, Ira; Turley, Shannon J; Wilson, Mark S; Mariathasan, Sanjeev; Molinero, Luciana; Merchant, Mark; West, Nathaniel R.
Afiliação
  • Huseni MA; Genentech, South San Francisco, CA 94080, USA. Electronic address: huseni.mahrukh@gene.com.
  • Wang L; Genentech, South San Francisco, CA 94080, USA.
  • Klementowicz JE; Genentech, South San Francisco, CA 94080, USA.
  • Yuen K; Genentech, South San Francisco, CA 94080, USA.
  • Breart B; Genentech, South San Francisco, CA 94080, USA.
  • Orr C; Genentech, South San Francisco, CA 94080, USA.
  • Liu LF; Genentech, South San Francisco, CA 94080, USA.
  • Li Y; Genentech, South San Francisco, CA 94080, USA.
  • Gupta V; Genentech, South San Francisco, CA 94080, USA.
  • Li C; Genentech, South San Francisco, CA 94080, USA.
  • Rishipathak D; Genentech, South San Francisco, CA 94080, USA.
  • Peng J; Genentech, South San Francisco, CA 94080, USA.
  • Senbabaoǧlu Y; Genentech, South San Francisco, CA 94080, USA.
  • Modrusan Z; Genentech, South San Francisco, CA 94080, USA.
  • Keerthivasan S; Genentech, South San Francisco, CA 94080, USA.
  • Madireddi S; Genentech, South San Francisco, CA 94080, USA.
  • Chen YJ; Genentech, South San Francisco, CA 94080, USA.
  • Fraser EJ; Genentech, South San Francisco, CA 94080, USA.
  • Leng N; Genentech, South San Francisco, CA 94080, USA.
  • Hamidi H; Genentech, South San Francisco, CA 94080, USA.
  • Koeppen H; Genentech, South San Francisco, CA 94080, USA.
  • Ziai J; Genentech, South San Francisco, CA 94080, USA.
  • Hashimoto K; Genentech, South San Francisco, CA 94080, USA.
  • Fassò M; Genentech, South San Francisco, CA 94080, USA.
  • Williams P; Genentech, South San Francisco, CA 94080, USA.
  • McDermott DF; Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
  • Rosenberg JE; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
  • Powles T; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, UK.
  • Emens LA; University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, PA 15213, USA.
  • Hegde PS; Genentech, South San Francisco, CA 94080, USA.
  • Mellman I; Genentech, South San Francisco, CA 94080, USA.
  • Turley SJ; Genentech, South San Francisco, CA 94080, USA.
  • Wilson MS; Genentech, South San Francisco, CA 94080, USA.
  • Mariathasan S; Genentech, South San Francisco, CA 94080, USA.
  • Molinero L; Genentech, South San Francisco, CA 94080, USA.
  • Merchant M; Genentech, South San Francisco, CA 94080, USA.
  • West NR; Genentech, South San Francisco, CA 94080, USA. Electronic address: west.nathaniel@gene.com.
Cell Rep Med ; 4(1): 100878, 2023 01 17.
Article em En | MEDLINE | ID: mdl-36599350

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucina-6 / Neoplasias / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Cell Rep Med Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Interleucina-6 / Neoplasias / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Cell Rep Med Ano de publicação: 2023 Tipo de documento: Article